Every cell therapy and gene therapy is unique and has different scientific and regulatory challenges. Our expert teams have a proven track-record in both product types that can support you at every step of the development journey.
- Designated Subject Matter Experts for gene therapies and cell therapies across scientific, regulatory and commercialization disciplines
- Dedicated experts in Rare Diseases, Pediatrics, Oncology and cellular immunotherapy
- Patient-centric approaches improve study recruitment, incorporate the voice of the patient and apply cutting-edge decentralized clinical trial (DCT) models